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Structural and electrostatic potential profiles of thy-
roxine (T4) have been investigated and compared with
milrinone and amrinone using ab initio (3-21 G) quan-
tum chemical method. The optimized structure of thy-
roxine is observed to be essentially similar to its crys-
tallographic structure. The calculated electronic profiles
of the three molecules indicate that only milrinone has
structural and electrostatic homology between the phe-
nolic ring of thyroxine and the substituted ring of milri-
none. The electrostatic homology as a consequence of
the twisted structure and reduced torsional flexibility of
milrinone may be responsible for its observed thyromi-
metic potential towards Ca2+ -ATPase.
In recent years many new classes of compounds
have been developed to tackle effectively the con-
gestive heart failure by favourably altering the
ventricular loading conditions and myocardial
contractility'. One such class of compounds are the
bipyridine cardiotonics which are nonglycosidic
positive inotropic agents and have been studied
quite extensively during the past decade'". Milri-
none and amrinone are the two bipyridine car-
diotonics particularly of interest for their inotropic
and peripheral vasodilatory properties'. Cody
et al. 1 have reported that milrinone, but not amri-
none, stimulates myocardial Ca2+-ATPase in a
manner similar to thyroid hormones. Crystallo-
graphic studies have shown that milrinone has
structural homology with thyroid hormones'. Thy-
roid hormones are iodinated amino acids, synthe-
sized in the thyroid gland and stored as amino acid
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residues of thyroglobulin". 3,5,3',5' -tetraiodo-L-
thyronine (T4) (Figure 1), known as thyroxine, was
one of the first biologically active form of thyroid
hormones isolated by Kendall7 and synthesized by
Harington and Barger". These hormones are well
known for their regulatory function in cell growth
and metabolism and have proven evidence to exert
direct effects on modulation of cardiac output and
cholesterol levels". The cardiac effects have been
speculated to be a result of thyroid hormone inter-
actions with the cardiac receptors 10. Although the
mechanism of the inotropic actions of thyroxine
and milrinone is not yet clearly understood, the
study of structure-function relationships of the
hormone and potent inotropic agents has been rec-
ognized as extremely important towards under-
standing the problem". From theoretical ab initio
level calculations, we have reported earlier":" that
the electronic and conformational features of mil-
rinone are distinctly different from those of amri-
none and this difference could be linked to the
greater cardiotonic potency for milrinone. In con-
tinuation of our interest in the mechanism of action
of the 'cardiotonic agents":" the present study had
been designed to assess theoretically the structural
homology between thyroxine/milrinone and thy-
roxine/amrinone from an electronic point of view
and also to make an attempt to understand the thy-
romimetic potential of milrinone in the Ca2+-
ATPase enzyme system". Since three-dimensional
molecular electrostatic potential (MEP) profiles
can provide a wealth of information for assessing
the electronic structures of molecules" particularly
when biological processes are involved", we have
examined in the present paper the results of ab ini-
tio (3-21 G level) calculations on the structural and
electrostatic potential profiles of thyroxine and
have compared them with those of amrinone and
milrinone.
Method
Geometry optimization of thyroxine was per-
formed at the ab initio quantum chemical level by
using the 3-21G split valence basis set as imple-
mented in the Gaussian 94 package". The geome-
tries of milrinone and amrinone were also opti-
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Figure l-{)ptimized structural parameters of thyroxine (T4)
calculated at 3-21 G ab initio level.
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mized at 3-21G level for comparison with thyrox-
ine. The 3-21G split-valence basis set uses 3
primitive Gaussian functions for the core orbitals
and a two/one split for valence function. This
quantum chemical method has been well docu-
mented in.Iiterature" as a method which can pro-
vide a good compromise between economy and
accuracy for the molecule as large as in the present
investigation.
The three-dimensional molecular electrostatic
potential (MEP) maps of thyroxine, milrinone and
amrinone were generated at -10.0 kcallmol isosur-
face using the graphics mode of the software
SPARTAN21• The electrostatic potentials were
sample over the entire accessible surface of a
molecule (corresponding roughly to a van der
Waals contact surface) which provides a measure
of charge distribution from the point of view of an
approaching reagent. The regions of positive elec-
trostatic potential indicate excess positive charge,
i.e. repulsion for the positively-charged test probe,
while regions of negative potential indicate areas
of excess negative charge, i.e., attraction of the
positively charged test probe.
Results and Discussion
The optimized structural parameters of thyrox-
ine are shown in Figure 1. The structure shows that
the biphenyl ether moiety is twist-skewed. The
structure analysis based on crystallographic study'
also suggests a similar conformation of the mole-
cule. The study reports the torsional angle about
the ether bond to be -1130 and the calculated tor-
sional angle is observed to be -91.10. Other struc-
tural parameters are also closely related. Thus, it
may be summed up that the calculated geometry of
thyroxine is essentially similar to the crystal ge-
ometry within limits of constraints of the two dif-
ferent methods of structural evaluations. The opti-
mized structural parameters for milrinone and am-
rinone together with their two-dimensional mo-
lecular electrostatic profiles have been reported by
us earlier'S". Although our results indicate twisted
structures for both amrinone and milrinone, the
reduced conformational flexibility of milrinone
and its consequent fall-out on the molecular elec-
trostatic potential profile were observed to be the
main two factors different from amrinone which
could be linked to its greater cardiotonic potency.
940 INDIAN J. CHEM. SEC B, OCTOBER 1997
The three-dimensional molecular electrostatic po- three compounds is observed to be devoid of
tential (MEP) profiles (at -10.0 kcallmol) of milri- negative potential which would indicate the possi-
none, amrinone and thyroxine (T4) together with bility of preferential nucleophilic attack over the
the profiles of best fit superimposition of milri- aromatic ring planes of the compounds. The nega-
none/thyroxine and amrinone/thyroxine are pre- tive potential zones of the compounds are observed
sented in Figure 2. These 3-D MEP contours to be localized. The profile for milrinone (FigureZ,
would indicate an equipotential energy of -10.0 top left) shows two distinctly separated negative
kcallmol that would be felt by a test positive potential areas: one large extended zone by the
charge placed at a any point .on the grid. The carbonyl oxygen and the cyano nitrogen atoms
choice of electrostatic potential profiles at -10.0 which is most likely due to the proximity of oxy-
kcal/mol is primarily to account for the long range gen and nitrogen electron lone pairs and another
recognition interactions. It is believed" that this smaller localized zone by the pyridinium nitrogen
recognition interaction occurs when the interacting atom of the other aromatic ring. The profile of am-
molecules are at a relatively large distance of sepa- rinone (Figure 2, top right) shows two similar
ration prior to any charge polarization or covalent negative potential zones: one by the pyridinium
bond formation. Inspection of the profiles indicates nitrogen atom of almost similar bulk as that of mil-
two distinctly separated negative arid positive po- rinone and another localized smaller zone by the
tential zones. The aromatic ring plane of all the carbonyl oxygen atom, which is neither extended
Figure 2-Three-dimensional molecular electrostatic potential profiles (MEPs) calculated at -10.0 kcaVmol. (Top left): milri-
none, (Top right): amrinone, (Center): thyroxine (T.) (Bottom left): superimposing milrinoneitbyroxine (T.), (Bottom right):
superimposing amrinoneithyroxine (T.).
and nor as broad as observed for milrinone. The
profile for thyroxine (T4) (Figure 2, center) shows
four localized negative potential zones: (i) by the
3' -iodine and 4' -oxygen atoms of the iodophenolic
ring which is fairly broad and extended, (ii) by the
ether oxygen extended upto the ring iodine atom,
(iii) by the nitrogen atom of the -NH2 group of the
chain, and (iv) a zone around the carboxyl moiety.
In order to compare the electrostatic homology,
the MEP profiles of milrinone (Figure 2, bottom
left)and amrinone (Figure 2, bottom right) were
superimposed onto that of thyroxine. The best fit
of the two structures is observed from the super-
imposition of substituted milrinone ring profile
with the iodophenolic ring of the thyroxine. The
broad extended negative potential zone by the
cyano and keto groups of milrinone is observed to
engulf the negative potential zone by the 5'-iodine
atom and 4' -hydroxyl group of the hormone. A
similar superimposition profile of amrinone with
thyroxine does not fit at all. The crystal structure
analysis' has also shown that this superposition can
provide the best structural homology between the
chemical and electronic properties of the hormone
and milrinone. Thus, it is not only the steric simi-
larity of the bulks of cyano and carbonyl groups of
milrinone with 5'-iodine and 4'-oxygen functions
of thyroxine but also the electrostatic similarity of
the two molecules in this portion perhaps controls
the Ca2+-ATPase enzymatic activity. Amrinone is
perhaps inactive, because the negative potential
zone by the amino and carbonyl groups of amri-
none could not superimpose with that of thyroxine.
The electronic contribution of the cyano group of
milrinone appears to be crucial for its activity. The
importance of both steric and electronic effect of
the cyano group ofmilrinone towards Ca2+-ATPase
activity had been suggested earlier.
Conclusion
The results of the present investigation are con-
sistent with the reported crystallographic observa-
tions. The broad and extended negative potential
zone by the cyano and carbonyl oxygen atom of
milrinone are observed to superimpose well with the
negative potential zone by the 5'-iodine and 4'-
oxygen atoms of the iodophenolic ring of thyrox-
ine and this feature appears to be crucial for Ca2+_
ATPase activity. Thus, from this theoretical study
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the thyromimetic potential of milrinone could be
fairly established by comparing both the steric and
electronic properties of the molecules. The aro-
matic ring planes are observed to be devoid of
negative potential and this is a common feature of
all the compounds. Therefore, an analysis of the
three-dimensional MEP profiles should aid in the
designing of this class of inotropic agents.
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